237 related articles for article (PubMed ID: 33129341)
1. A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.
Meyer JP; Culbert GJ; Azbel L; Bachireddy C; Kurmanalieva A; Rhodes T; Altice FL
Harm Reduct J; 2020 Oct; 17(1):86. PubMed ID: 33129341
[TBL] [Abstract][Full Text] [Related]
2. Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.
Liberman AR; Bromberg DJ; Azbel L; Rozanova J; Madden L; Meyer JP; Altice FL
Int J Drug Policy; 2021 Aug; 94():103209. PubMed ID: 33838398
[TBL] [Abstract][Full Text] [Related]
3. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
4. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
[TBL] [Abstract][Full Text] [Related]
5. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
[TBL] [Abstract][Full Text] [Related]
6. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
7. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
[TBL] [Abstract][Full Text] [Related]
8. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
Chakrapani V; Kamei R; Kipgen H; Kh JK
Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
[TBL] [Abstract][Full Text] [Related]
9. Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.
Liberman AR; Bromberg DJ; Litz T; Kurmanalieva A; Galvez S; Rozanova J; Azbel L; Meyer JP; Altice FL
PLoS One; 2022; 17(10):e0276723. PubMed ID: 36282864
[TBL] [Abstract][Full Text] [Related]
10. The Global State of Harm Reduction in Prisons.
Sander G; Shirley-Beavan S; Stone K
J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
[TBL] [Abstract][Full Text] [Related]
11. A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment.
Vagenas P; Azbel L; Polonsky M; Kerimi N; Mamyrov M; Dvoryak S; Altice FL
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S25-31. PubMed ID: 23932844
[TBL] [Abstract][Full Text] [Related]
12. Injecting substance use in prisons in the United States: a case for needle exchange programs.
Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
[TBL] [Abstract][Full Text] [Related]
13. "It Goes on Everywhere": Injection Drug Use in Canadian Federal Prisons.
van der Meulen E
Subst Use Misuse; 2017 Jun; 52(7):884-891. PubMed ID: 28426354
[TBL] [Abstract][Full Text] [Related]
14. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
15. A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan.
Azbel L; Rozanova J; Michels I; Altice FL; Stöver H
Harm Reduct J; 2017 Jul; 14(1):43. PubMed ID: 28693573
[TBL] [Abstract][Full Text] [Related]
16. People who inject drugs in prison: HIV prevalence, transmission and prevention.
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
[TBL] [Abstract][Full Text] [Related]
17. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.
Azbel L; Polonsky M; Wegman M; Shumskaya N; Kurmanalieva A; Asanov A; Wickersham JA; Dvoriak S; Altice FL
Int J Drug Policy; 2016 Nov; 37():9-20. PubMed ID: 27455177
[TBL] [Abstract][Full Text] [Related]
18. Implementing methadone maintenance treatment in prisons in Malaysia.
Wickersham JA; Marcus R; Kamarulzaman A; Zahari MM; Altice FL
Bull World Health Organ; 2013 Feb; 91(2):124-9. PubMed ID: 23554524
[TBL] [Abstract][Full Text] [Related]
19. Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study.
Smith LR; Shumskaia N; Kurmanalieva A; Patterson TL; Werb D; Blyum A; Algarin AB; Yeager S; Cepeda J
Harm Reduct J; 2022 May; 19(1):53. PubMed ID: 35614508
[TBL] [Abstract][Full Text] [Related]
20. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
